Molecular Vision Strengthens Board, Appoints Dr Chris Hand as Non-Executive Director
Dr Hand has over 20 years’ experience in the medical diagnostics market. He was CEO of medical diagnostics company Cozart plc until its acquisition by Concateno plc in October 2007. Dr Hand co-founded Cozart with £30,000 in 1993, led a successful VC fundraising in 2001 and AIM flotation in 2004 before the £65m sale of the business in late 2007. He remained a non-executive director of Concateno until its acquisition by Inverness Medical Innovations in 2009. Dr Hand has a DPhil in biochemistry from Oxford University.
Most read news
Topics
Organizations
Other news from the department people
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.